Lars Erik Krag

668 total citations
8 papers, 509 citations indexed

About

Lars Erik Krag is a scholar working on Genetics, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Lars Erik Krag has authored 8 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Lars Erik Krag's work include Estrogen and related hormone effects (7 papers), Bone health and treatments (3 papers) and Cancer Risks and Factors (3 papers). Lars Erik Krag is often cited by papers focused on Estrogen and related hormone effects (7 papers), Bone health and treatments (3 papers) and Cancer Risks and Factors (3 papers). Lars Erik Krag collaborates with scholars based in Norway, United States and Italy. Lars Erik Krag's co-authors include Anne Irene Hagen, Per Eystein Lønning, Jürgen Geisler, Ellen Schlichting, Anna Polli, Jolanda Paolini, Taka Ashikaga, David N. Krag, Erik Snorre Øfjord and Ernst A. Lien and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and World Journal of Surgery.

In The Last Decade

Lars Erik Krag

8 papers receiving 499 citations

Peers

Lars Erik Krag

ONCOL

GENET

OSM

PFM

S. Ashley United Kingdom

Joern Hilfrich Germany

G. Gademann Germany

Carol H. Wasilauskas United States

Judy-Anne W. Chapman Canada

Juliette Murray United Kingdom

Kate Whelan United States

Julie Iddon United Kingdom

A. Fini Italy

Messan G. Amewou-Atisso United States

S. Ashley United Kingdom

Lars Erik Krag

349 ×1.1

ONCOL

316 ×1.1

GENET

111 ×0.6

186 ×1.4

OSM

32 ×0.4

PFM

Citations per year, relative to Lars Erik Krag Lars Erik Krag (= 1×) peers S. Ashley

Countries citing papers authored by Lars Erik Krag

Since Specialization

Citations

This map shows the geographic impact of Lars Erik Krag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Erik Krag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Erik Krag more than expected).

Fields of papers citing papers by Lars Erik Krag

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Erik Krag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Erik Krag. The network helps show where Lars Erik Krag may publish in the future.

Co-authorship network of co-authors of Lars Erik Krag

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Erik Krag. A scholar is included among the top collaborators of Lars Erik Krag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Erik Krag. Lars Erik Krag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Ashikaga, Taka, et al.. (2012). The False‐Negative Rate of Sentinel Node Biopsy in Patients with Breast Cancer: A Meta‐Analysis. World Journal of Surgery. 36(9). 2239–2251. 119 indexed citations

Geisler, Jürgen, Per Eystein Lønning, Lars Erik Krag, et al.. (2006). Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: A randomised, placebo-controlled study. European Journal of Cancer. 42(17). 2968–2975. 84 indexed citations

Lønning, Per Eystein, Jürgen Geisler, Lars Erik Krag, et al.. (2006). Vitamin D deficiency: A threat to bone health in breast cancer patients during adjuvant treatment with aromatase inhibitors. Journal of Clinical Oncology. 24(18_suppl). 554–554. 12 indexed citations

Lønning, Per Eystein, Jürgen Geisler, Lars Erik Krag, et al.. (2005). Changes in bone metabolism after 2 years’ treatment with exemestane (E) in postmenopausal women with early breast cancer (EBC) at low risk: Follow-up (FU) results of a randomized placebo-controlled study. Journal of Clinical Oncology. 23(16_suppl). 531–531. 11 indexed citations

Lønning, Per Eystein, Jürgen Geisler, Lars Erik Krag, et al.. (2005). Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer. Journal of Clinical Oncology. 23(22). 5126–5137. 236 indexed citations

Krag, Lars Erik, Jürgen Geisler, Per Eystein Lønning, et al.. (2004). Lipid and coagulation profile in postmenopausal women with early breast cancer at low risk treated with exemestane: A randomized, placebo-controlled study. Journal of Clinical Oncology. 22(14_suppl). 650–650. 10 indexed citations

Geisler, Jürgen, Per Eystein Lønning, Lars Erik Krag, et al.. (2004). Estrogens and bone metabolism in postmenopausal women with early breast cancer at low risk treated with exemestane: a randomized placebo-controlled study. Journal of Clinical Oncology. 22(14_suppl). 531–531. 14 indexed citations

Lønning, Per Eystein, Jürgen Geisler, Lars Erik Krag, et al.. (2004). Effect of exemestane on bone: A randomized placebo controlled study in postmenopausal women with early breast cancer at low risk. Journal of Clinical Oncology. 22(14_suppl). 518–518. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact